Thomas Civik Pyxis Oncology, Inc. (PYXS) insider trading activity

PYXS Quotes by TradingView

Thomas Civik is of Pyxis Oncology, Inc.. Currently has a direct ownership of 206,186 shares of PYXS, which is worth approximately $723,712. The most recent transaction as insider was on Mar 24, 2023, when has been sold 139,355 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 206K
0% 3M change
0% 12M change
Total Value Held $723,712

Thomas Civik Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 24 2023
BUY
Grant, award, or other acquisition
-
139,355 Added 40.33%
206,186 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
-
66,831 Added 50.0%
66,831 Common Stock

Also insider at

FPRX
FIVE PRIME THERAPEUTICS, INC.
President and CEO
RPTX
Repare Therapeutics Inc. Healthcare
TC

Thomas Civik

St Laurent, A8

Track Institutional and Insider Activities on PYXS

Follow Pyxis Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PYXS shares.

Notify only if

Insider Trading

Get notified when an Pyxis Oncology, Inc. insider buys or sells PYXS shares.

Notify only if

News

Receive news related to Pyxis Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PYXS